Cognizant, Tata Consultancy Services, Infosys, and Wipro have announced plans to deploy more than 200,000 Microsoft Copilot licenses in their enterprises – over 50,000 per company – in what Microsoft is calling a new benchmark for enterprise-scale adoption of generative AI.
Advertisement
Zara is testing how far generative AI can be pushed into everyday retail operations, starting with a part of the business that rarely gets attention in technology discussions: product imagery.
Popular News
AI spending in Asia Pacific continues to rise, yet many companies still struggle to get value from their AI projects. Much of this comes down to the infrastructure that supports AI, as most systems are not built to run inference at the speed or scale real applications need. Industry studies show many projects miss their ROI goals even after heavy investment in GenAI tools because of the issue.
We’ve all seen the headlines: a third of US college students say they use ChatGPT for writing tasks at least once a month. The share of US teens turning to the same tool for schoolwork doubled between 2023 and 2024. Generative AI tools overall are a fixture of life for seven out of ten teens.
Alibaba’s recently launched Qwen AI app has demonstrated remarkable market traction, accumulating 10 million downloads in the seven days since its public beta release – a velocity that exceeds the early adoption rates of ChatGPT, Sora, and DeepSeek.
With its WorldGen system, Meta is shifting the use of generative AI for 3D worlds from creating static imagery to fully interactive assets.
Advertisement
Producing digital advertising at global scale has become less about one standout campaign and more about volume, speed, and consistency. For consumer brands operating across dozens of markets, the challenge is not creativity alone, but how to keep content flowing without repeating expensive production cycles.
Producing digital advertising at global scale has become less about one standout campaign and more about volume, speed, and consistency. For consumer brands operating across dozens of markets, the challenge is not creativity alone, but how to keep content flowing without repeating expensive production cycles.
Modern software delivery depends on the reliability, integrity, and security of container images. As organisations migrate to microservices, automated CI/CD pipelines, and multi-cloud architectures, the container image becomes more than a packaging mechanism, it becomes a security boundary. A single vulnerability embedded in an image can replicate in clusters, environments, and deployments, creating widespread risk for applications that rely on speed and repeatability.
A recent industry report [PDF] argues that Britain’s railway network could carry an extra billion journeys by the mid-2030s, building on the 1.6 billion passenger rail journeys recorded to year-end March 2024. The next decade will involve a combination of complexity and control, as more digital systems, data, and interconnected suppliers create the potential for more points of failure.
Arm Holdings has positioned itself at the centre of AI transformation. In a wide-ranging podcast interview, Vince Jesaitis, head of global government affairs at Arm, offered enterprise decision-makers look into the company’s international strategy, the evolution of AI as the company sees it, and what lies ahead for the industry.
AI chip shortage became the defining constraint for enterprise AI deployments in 2025, forcing CTOs to confront an uncomfortable reality: semiconductor geopolitics and supply chain physics matter more than software roadmaps or vendor commitments.
AI chip shortage became the defining constraint for enterprise AI deployments in 2025, forcing CTOs to confront an uncomfortable reality: semiconductor geopolitics and supply chain physics matter more than software roadmaps or vendor commitments.
Artificial intelligence and big data are reshaping digital marketing by providing new insights into consumer behaviour. The technologies allow marketers to create more personalised and effective strategies. As the digital world evolves, businesses must adapt to stay competitive.
Under China’s push to clean up its energy system, AI is starting to shape how power is produced, moved, and used — not in abstract policy terms, but in day-to-day operations.
Cognizant, Tata Consultancy Services, Infosys, and Wipro have announced plans to deploy more than 200,000 Microsoft Copilot licenses in their enterprises – over 50,000 per company – in what Microsoft is calling a new benchmark for enterprise-scale adoption of generative AI.
Solana’s high-speed platform is fast becoming the preferred home for independent AI programmes. It comes at a time when advanced uses of technology have led to significant increases in cyberattacks. This article details the escalating malware threats for the cryptocurrency community.
Solana’s high-speed platform is fast becoming the preferred home for independent AI programmes. It comes at a time when advanced uses of technology have led to significant increases in cyberattacks. This article details the escalating malware threats for the cryptocurrency community.
For a company built on intellectual property, scale creates a familiar tension. Disney needs to produce and distribute content across many formats and audiences, while keeping tight control over rights, safety, and brand consistency. Generative AI promises speed and flexibility, but unmanaged use risks creating legal, creative, and operational drag.
Artificial intelligence has been part of the insurance sector for years – the Finance function in many businesses is often the first to automate. But what’s remarkable in the instance of AI is how directly the technology is woven into day-to-day operational work. Not sitting in the background as a niche modelling capability, AI is now used in places where insurers spend most of their time and money: claims handling, underwriting, and running complex programmes.
Big Pharma’s AI race extends across drug discovery, development, and clinical trials—but AstraZeneca has distinguished itself by deploying AI clinical trials technology at an unprecedented public health scale.
The content available on this website (including text, graphics, images, and information) is intended for general informational purposes only. Materials, details, terms of use, and descriptions presented on these pages may be changed without prior notice.
